Last week, a Twitter user asked Dr. Charles Brenner for research on the potential neuroprotective benefits of NAD+ vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Consumer Anecdotes). Here’s how Dr. Brenner responded:

Related:

  • Dr. Brenner’s 2016 Paper mentioned above (Link)
  • New Phase 1 Clinical Trial Results Show Nicotinamide Riboside (NR) as a Potential Neuroprotective Therapy for Parkinson’s Disease (Link)
  • FAQs (and anecdotes) on the Potential for Treating Neuropathy with vitamin supplement Nicotinamide Riboside “NR” (Link)
  • Clinical Trials — NR and Neuropathy (Link)
  • Clinical Trials — NR and Parkinson’s (Link)

FOLLOW us on Twitter @RaisingNAD